Similarly, new advances in the molecular biology of cancer cells reveal that cancer stem cells (CSCs) and cancer resistant cells (CRCs) escape cell death by activating the survival pathway (e.g. NF-kB) and by hyperactivating DNA repair enzyme Poly ADP ribose polymerase (PARP) which repairs DNA breaks caused by oncology drugs. The gene discussed is NFKB1; the disease is cancer.